Home › Conditions › Biologics & Specialty Drugs

Biologics & Specialty Drugs — Insurance Denial Appeal Guides

Insurance denials for Biologics & Specialty Drugs are common — but so are successful appeals. Below are all available guides covering the specific denial reasons, required documentation, and appeal strategies that work for Biologics & Specialty Drugs claims.

~60% of properly-filed appeals are overturned. Most patients never appeal — giving up money they're entitled to.

Asthma Biologic Denied by Insurance: Appeal Guide

Severe asthma biologic denied? Learn how to appeal using eosinophil counts, IgE levels, and GINA guidelines for Dupixent

Asthma Biologic Treatment Denied by Insurance? How to Appeal

Insurance denying Dupixent, Fasenra, Nucala, Tezspire, or Xolair for severe asthma? Learn the eosinophil count, IgE thre

Atopic Dermatitis Biologic Denied: Appeal Guide

Eczema biologic denied by insurance? Appeal using EASI/SCORAD scores, failed topical records, and AAD guidelines for Dup

Biologic Drug Denied by Insurance? How to Fight Back

Insurance denied your biologic medication (Humira, Enbrel, Dupixent, Cosentyx)? Step therapy and prior auth denials are

Crohn's Disease Biologic Denied: Appeal Guide

Crohn's disease biologic denied by insurance? Appeal with step therapy records, colonoscopy evidence, and ACG guidelines

Humira (Adalimumab) Denied: How to Appeal Biosimilar Switching and Step Therapy

Insurance denied Humira or forced a switch to an adalimumab biosimilar? Learn how to appeal step therapy requirements fo

Humira (Adalimumab) Denied by Insurance: How to Appeal

Insurance denied Humira for RA, Crohn's, or psoriasis? Learn why denials happen and how to appeal with clinical evidence

Insurance Denied Rheumatoid Arthritis Biologics — Your Appeal Guide

If your insurer denied biologics or JAK inhibitors for rheumatoid arthritis, learn how to appeal with ACR guidelines, st

Keytruda (Pembrolizumab) Denied by Insurance

Insurance denied Keytruda for cancer treatment? Understand PD-L1 testing requirements, prior auth rules, and how to appe

Keytruda (Pembrolizumab) Denied: Appealing PD-L1, MSI-H, and Off-Label Cancer Treatment Denials

Insurance denied Keytruda? Learn how to appeal pembrolizumab denials based on PD-L1 testing requirements, MSI-H/TMB-H cr

Psoriasis Biologic Denied by Insurance: Appeal

Psoriasis biologic denied? Use PASI, BSA, and DLQI scores plus AAD guidelines to win your appeal. This guide covers ever

RA Biologic Denied by Insurance: Complete Appeal Guide

Insurance denied your RA biologic? Learn how to appeal using CDAI/DAS28 scores, ACR guidelines, and step therapy documen

Ulcerative Colitis Biologic Denied: How to Appeal

UC biologic denied by insurance? Use Mayo scores, steroid dependence records, and ACG guidelines to build a winning appe

February 28, 2026

Humira Biosimilar Switching Denied? How to Appeal

Insurance companies are rapidly switching Humira patients to biosimilars. If you've been denied Humira or forced to swit

February 28, 2026

Humira Denied by Insurance? How to Appeal a Biologic Denial

Insurance denied Humira (adalimumab) for rheumatoid arthritis, Crohn's disease, psoriasis, or ankylosing spondylitis? St

February 28, 2026

Insurance Denied Your Biologic Drug? How to Appeal Step Therapy and Specialty Tier Denials

Biologic drug denials often involve step therapy, biosimilar substitution, or formulary tier barriers. Learn the formula

February 28, 2026

Keytruda Denied by Insurance? How to Appeal an Immunotherapy Denial

Insurance denied Keytruda (pembrolizumab) for cancer treatment? Immunotherapy denials are serious and frequently overtur

February 28, 2026

Keytruda or Opdivo Denied by Insurance? How to Appeal

Keytruda (pembrolizumab) and Opdivo (nivolumab) are FDA-approved checkpoint inhibitors for many cancers. Learn how to ap

February 22, 2026

Asthma Biologics Denied by Insurance? How to Appeal

Insurance denying dupilumab, mepolizumab, or benralizumab for asthma? Learn how to overcome step therapy requirements an

February 22, 2026

Biologic Drug for Rheumatoid Arthritis Denied? Fight Back

Biologic drugs are often the most effective treatment for rheumatoid arthritis, yet insurance denials are common. Learn

November 20, 2025

Humira/Adalimumab Insurance Denied? How to Appeal

Insurance denying coverage for Humira or adalimumab? Learn how to appeal biosimilar switching requirements, prior author

October 17, 2025

Biologic for Immune Conditions Insurance Denied? How to Appeal

Insurance denying a biologic for your immune condition? Learn how to challenge step therapy requirements, trial periods,

October 17, 2025

Biologics for Skin Conditions Insurance Denied? How to Appeal

Insurance denied a biologic for psoriasis, eczema, or another skin condition? Learn the coverage criteria, step therapy

Ready to fight your Biologics & Specialty Drugs denial?

Get a professional appeal letter citing your insurer's own clinical policy bulletins and published medical guidelines for Biologics & Specialty Drugs. 3 minutes, no login required.

Start My Free Appeal →